Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Effect of Vestibular Rehabilitation Combined With Dual-Task Training in Patients With Unilateral Vestibular Hypofunction (VRT-DT)

13 november 2026 bijgewerkt door: Danah Mohammed Alyahya, Majmaah University

The Effect of the Vestibular Rehabilitation Combined With Dual-task Training Among Unilateral Vestibular Hypofunction Patients.

Unilateral vestibular hypofunction (UVH) is a condition in which the balance system in one inner ear does not function properly. People with this condition may experience dizziness, blurred vision during head movements, difficulty maintaining balance, and problems walking, particularly when performing two tasks at the same time.

Vestibular rehabilitation is an exercise-based treatment designed to improve balance, gaze stability, and daily functioning. Dual-task training involves performing a physical activity while simultaneously completing a mental or another physical task, such as walking while counting backward.

The purpose of this study is to investigate whether combining dual-task training with vestibular rehabilitation is more effective than traditional vestibular rehabilitation alone in improving vestibular function, dizziness, balance, and walking ability in adults with unilateral vestibular hypofunction.

This study is a single-blind randomized controlled trial involving 50 adults aged 18 to 65 years with unilateral vestibular hypofunction. Participants will be randomly assigned to one of two groups. The first group will receive traditional vestibular rehabilitation, while the second group will receive vestibular rehabilitation combined with dual-task training. Both groups will complete two treatment sessions per week for four weeks, for a total of eight sessions.

Participants will undergo assessments before and after the four-week intervention to evaluate vestibular function, dizziness-related disability, balance, walking ability, attention, and working memory. The findings may help determine whether adding dual-task training provides additional benefits for people with unilateral vestibular hypofunction.

Studie Overzicht

Studietype

Ingrijpend

Inschrijving (Geschat)

50

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar tot 65 jaar (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Adults aged 18 to 65 years.
  • Patients with a physician-confirmed diagnosis of unilateral vestibular -hypofunction (UVH).
  • Male and female participants.
  • Ability to walk independently and safely for at least 6 meters.
  • Ability to attend at least 80% of the scheduled treatment sessions.

Exclusion Criteria:

  • Patients diagnosed with bilateral vestibular hypofunction.
  • Presence of neurological disorders that affect balance.
  • Presence of musculoskeletal disorders that affect balance.
  • Cognitive impairment affecting task performance, defined as a Montreal -Cognitive Assessment (MoCA) score below 26.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: VR Group

Participants in this group will receive traditional vestibular rehabilitation consisting of gaze stabilization exercises (VOR x1 and VOR x2), habituation exercises, and balance training. Balance exercises will include standing on firm and foam surfaces with eyes open and closed, tandem standing, tandem walking, and walking with head movements. The intervention will be delivered twice weekly for four weeks, totaling eight treatment sessions.

Participants will receive traditional vestibular rehabilitation consisting of gaze stabilization, habituation, and balance exercises. Gaze stabilization includes VOR x1 exercises (1-2 minutes, 2-3 times) and VOR x2 exercises (1 minute, 2-3 times), performed with horizontal and vertical head movements. Habituation exercises involve repeated symptom-provoking movements, such as bending, head rotation, and turning (3-5 repetitions, 2-3 times). Balance training includes standing on firm and foam surfaces with eyes open and closed, tandem standing (30 seconds, 3-5 repetitions), tandem walking (10 steps, 3-5 repetitions), and walking 6 meters with head turns (3-5 repetitions). Participants will attend two sessions per week for four weeks, totaling eight sessions.

Experimenteel: VR Group With Dual-Task Training

Participants in this group will receive vestibular rehabilitation combined with dual-task training. The intervention will involve performing vestibular and balance exercises simultaneously with cognitive or motor tasks, including backward counting, reciting months in reverse order, naming animals, digit recall, serial subtraction, backward spelling, and walking while carrying a cup of water. The intervention will be delivered twice weekly for four weeks, totaling eight treatment sessions.

Participants will receive vestibular rehabilitation combined with simultaneous cognitive or motor tasks. Exercises include VOR x1 while counting backward from 100; VOR x2 while reciting months in reverse order; standing on foam while naming animals; standing on foam with eyes closed while recalling digit sequences; tandem standing while subtracting seven repeatedly from 100; tandem walking while spelling a five-letter word backward; walking with head turns while carrying a cup of water; and walking 6 meters while counting backward from 50. The intervention combines vestibular and balance activities with secondary tasks to challenge cognitive-motor performance. Participants will attend two sessions per week for four weeks, totaling eight sessions.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Change in Vestibulo-Ocular Reflex (VOR) Gain
Tijdsspanne: Baseline and immediately after the 4-week intervention

Vestibulo-ocular reflex (VOR) gain will be assessed using the Video Head Impulse Test (vHIT), an objective measure of semicircular canal function. VOR gain will be measured before and after the four-week intervention to evaluate changes in vestibular function and compare the effects of traditional vestibular rehabilitation with vestibular rehabilitation combined with dual-task training.

Baseline and immediately after the 4-week intervention
Change in Vestibular Evoked Myogenic Potential (VEMP) Responses
Tijdsspanne: Baseline and immediately after the 4-week intervention

Otolith organ function will be assessed using cervical Vestibular Evoked Myogenic Potentials (cVEMP) to evaluate saccular function and ocular Vestibular Evoked Myogenic Potentials (oVEMP) to evaluate utricular function. Assessments will be conducted before and after the four-week intervention to investigate changes in otolith function and compare responses between the two intervention groups.

Baseline and immediately after the 4-week intervention

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Geschat)

15 november 2026

Primaire voltooiing (Geschat)

30 december 2026

Studie voltooiing (Geschat)

30 januari 2027

Studieregistratiedata

Eerst ingediend

13 november 2026

Eerst ingediend dat voldeed aan de QC-criteria

13 november 2026

Eerst geplaatst (Werkelijk)

19 november 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

19 november 2026

Laatste update ingediend die voldeed aan QC-criteria

13 november 2026

Laatst geverifieerd

1 november 2026

Meer informatie

Termen gerelateerd aan deze studie

Andere studie-ID-nummers

  • IRB-097-2026

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

ONBESLIST

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren